Article Text

PDF
Cardiovascular highlights from non-cardiology journals
  1. Steven M Bradley, JournalScan Editor

Statistics from Altmetric.com

Stent type and interrupted anti-platelet therapy does not correlate with adverse events after non-cardiac surgeries

Guidelines recommend delaying elective surgery in patients with drug eluting stent for one year after stent implantation to allow completion of 1 year of dual anti-platelet therapy without interruption. This recommendation is based on expert consensus and results in several clinical questions, including whether it is preferable to use a bare metal stent in patients with a potential for future surgery and whether this delay is excessive for patients considering surgery with other potential benefits (ie, knee replacement in patients with life-limiting osteoarthritis). Accordingly, the authors sought to understand the risk of major adverse cardiovascular events (MACE) following non-cardiac surgery among patients with coronary stents as a function of time since coronary stenting, stent type, and antiplatelet therapy …

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.